Obituaries

Harry Eagle, a pioneer in medical research, died June 12 in Port Chester, N.Y., at the age of 86. Eagle, who received the National Medal of Science in 1987, developed one of the first methods for creating Eagle growth medium, the compounds needed for the growth of human and animal tissue in a laboratory (Science, 129:252-4, 1959). He also contributed to the discovery that blood clotting is an enzyme process; advanced cancer chemotherapy; engineered a diagnostic test for syphilis; and identified

| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

Harry Eagle, a pioneer in medical research, died June 12 in Port Chester, N.Y., at the age of 86. Eagle, who received the National Medal of Science in 1987, developed one of the first methods for creating Eagle growth medium, the compounds needed for the growth of human and animal tissue in a laboratory (Science, 129:252-4, 1959). He also contributed to the discovery that blood clotting is an enzyme process; advanced cancer chemotherapy; engineered a diagnostic test for syphilis; and identified various medical uses of penicillin. Eagle graduated from Johns Hopkins University School of Medicine in 1927. He performed research there for the next 20 years. In 1947, he joined the National Cancer Institute and later the National Microbiological Institute until 1959. From 1961 until his retirement in 1988, he was director of the Albert Einstein College of Medicine Cancer Research Center in the Bronx. Albert Gordon, a physiologist who ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies